FDA/CDC

‘Reassuring’ data on COVID-19 vaccines in pregnancy


 

Vaccination could benefit infants

In addition to the new safety data, experts continue to remind clinicians and the public that vaccination during pregnancy could benefit offspring. The unborn babies of pregnant women who receive the COVID-19 vaccine could be protected from the virus for the first several months of their lives, said White House COVID-19 czar Anthony Fauci, MD, at a briefing on March 10.

“We’ve seen this with many other vaccines,” Dr. Fauci said. “That’s a very good way you can get protection for the mother during pregnancy and also a transfer of protection for the infant, which will last a few months following the birth.”

Dr. Fauci also noted that the same vaccine platform used in Johnson & Johnson’s COVID-19 vaccine was successfully used for Ebola in pregnant women in Africa.

Dr. Shimabukuro has reported no relevant financial relationships.

Lindsay Kalter contributed to the reporting for this story.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Journal of Clinical Outcomes Management
COVID-related immunization gaps portend return of preventable infections
Journal of Clinical Outcomes Management
Pregnant patients with severe COVID-19 disease at increased risk of complications
Journal of Clinical Outcomes Management
First pill for COVID-19 could be ready by year’s end
Journal of Clinical Outcomes Management
Don’t delay: Cancer patients need both doses of COVID vaccine
Journal of Clinical Outcomes Management
Decline in child COVID-19 cases picks up after 2-week slowdown
Journal of Clinical Outcomes Management
Some with long COVID see relief after vaccination
Journal of Clinical Outcomes Management
Updated recommendations released on COVID-19 and pediatric ALL
Journal of Clinical Outcomes Management
COVID-19 virus reinfections rare; riskiest after age 65
Journal of Clinical Outcomes Management
High obesity rates in Southern states magnify COVID threats
Journal of Clinical Outcomes Management